chr2-178569952-A-AAGGAGGGCTTGGTTCACTAAGTT
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_001267550.2(TTN):c.76179_76180insAACTTAGTGAACCAAGCCCTCCT(p.Ser25394AsnfsTer30) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,460,424 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. P25393P) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001267550.2 frameshift
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001267550.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TTN | NM_001267550.2 | MANE Select | c.76179_76180insAACTTAGTGAACCAAGCCCTCCT | p.Ser25394AsnfsTer30 | frameshift | Exon 326 of 363 | NP_001254479.2 | ||
| TTN | NM_001256850.1 | c.71256_71257insAACTTAGTGAACCAAGCCCTCCT | p.Ser23753AsnfsTer30 | frameshift | Exon 276 of 313 | NP_001243779.1 | |||
| TTN | NM_133378.4 | c.68475_68476insAACTTAGTGAACCAAGCCCTCCT | p.Ser22826AsnfsTer30 | frameshift | Exon 275 of 312 | NP_596869.4 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TTN | ENST00000589042.5 | TSL:5 MANE Select | c.76179_76180insAACTTAGTGAACCAAGCCCTCCT | p.Ser25394AsnfsTer30 | frameshift | Exon 326 of 363 | ENSP00000467141.1 | ||
| TTN | ENST00000446966.2 | TSL:1 | c.76023_76024insAACTTAGTGAACCAAGCCCTCCT | p.Ser25342AsnfsTer30 | frameshift | Exon 324 of 361 | ENSP00000408004.2 | ||
| TTN | ENST00000436599.2 | TSL:1 | c.75903_75904insAACTTAGTGAACCAAGCCCTCCT | p.Ser25302AsnfsTer30 | frameshift | Exon 324 of 361 | ENSP00000405517.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460424Hom.: 0 Cov.: 40 AF XY: 0.00000275 AC XY: 2AN XY: 726366 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Dilated cardiomyopathy 1G Pathogenic:1
This sequence change inserts 23 nucleotides in exon 326 of the TTN mRNA (c.76179_76180ins23), causing a frameshift at codon 25394. This creates a premature translational stop signal (p.Ser25394Asnfs*30) and is expected to result in an absent or disrupted protein product. This variant is found in the A-band of this gene. Truncating variants in the A-band of TTN are likely pathogenic (PMID: 25589632). This particular variant has been already found in an individual with personal and family history of dilated cardiomyopathy (Invitae database). For these reasons, this variant has been classified as Pathogenic.
not provided Pathogenic:1
Cardiovascular phenotype Pathogenic:1
The c.48984_48985ins23 pathogenic mutation, located in coding exon 153 of the TTN gene, results from an insertion of 23 nucleotides at position 48984, causing a translational frameshift with a predicted alternate stop codon (p.S16329Nfs*30). This exon is located in the A-band region of the N2-B isoform of the titin protein and is constitutively expressed in TTN transcripts (percent spliced in or PSI 100%). This variant was reported in individual(s) with features consistent with dilated cardiomyopathy (external communication; Ambry internal data). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This variant is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. While truncating variants in TTN are present in 1-3% of the general population, truncating variants in the A-band are the most common cause of dilated cardiomyopathy (Herman DS et al. N. Engl. J. Med., 2012 Feb;366:619-28; Roberts AM et al. Sci Transl Med, 2015 Jan;7:270ra6). TTN truncating variants encoded in constitutive exons (PSI >90%) have been found to be significantly associated with DCM regardless of their position in titin (Schafer S et al. Nat. Genet., 2017 01;49:46-53; Akhtar MM et al. Circ Heart Fail, 2020 Oct;13:e006832; Massier M et al. Clin Genet, 2025 Jan). Based on the supporting evidence, this variant is interpreted as a disease-causing mutation.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at